Acromegaly  >>  Signifor LAR (pasireotide long acting release)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Signifor LAR (pasireotide long acting release) / Recordati
NCT00446082: Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Completed
1
85
Europe, Canada, US
Pasireotide
Novartis Pharmaceuticals
Carcinoid Tumor, Acromegaly
11/13
11/13
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Signifor LAR (pasireotide long acting release) / Recordati
NCT00446082: Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Completed
1
85
Europe, Canada, US
Pasireotide
Novartis Pharmaceuticals
Carcinoid Tumor, Acromegaly
11/13
11/13

Download Options